A patient with a significant pulmonary embolism is receiving intravenous heparin and oxygen supplementation. Despite these treatments, the patient's blood pressure is trending downward, indicating potential cardiogenic shock. Which intervention should the nurse anticipate the healthcare provider will order next to address the risk of shock?

A) Initiate thrombolytic therapy

B) Increase the dose of intravenous heparin

C) Administer intravenous fluids aggressively

D) Start oral anticoagulation therapy

A patient diagnosed with a significant pulmonary embolism is on intravenous heparin and supplemental oxygen. Despite these interventions, the patient's blood pressure is decreasing, indicating potential cardiogenic shock. What is the most appropriate nursing action to prioritize at this time?

B) Prepare the patient for thrombolytic therapy to rapidly reduce the clot burden.

A) Increase the rate of intravenous fluid administration to support blood pressure.

B) Prepare the patient for thrombolytic therapy to rapidly reduce the clot burden.

C) Decrease oxygen supplementation to prevent oxygen toxicity.

D) Monitor the patient's urine output to assess kidney function.

A patient with a pulmonary embolism is exhibiting signs of increased respiratory distress and right ventricular strain. The medical team is considering the use of thrombolytic therapy. Which nursing intervention is most appropriate to prioritize at this time?

B) Monitor vital signs and oxygen saturation closely while preparing for potential escalation of care

A) Initiate STAT thrombolytic therapy to immediately reduce clot burden

B) Monitor vital signs and oxygen saturation closely while preparing for potential escalation of care

C) Administer additional intravenous fluids to support blood pressure

D) Request an urgent consult for mechanical circulatory support

A patient receiving anticoagulation therapy for a pulmonary embolism is now experiencing increased respiratory distress, elevated jugular venous pressure, and borderline blood pressure while on oxygen support. Which intervention should the nurse prioritize to address the patient's current hemodynamic status?

B) Prepare the patient for thrombolytic therapy

A) Increase fluid administration to improve blood pressure

B) Prepare the patient for thrombolytic therapy

C) Position the patient in high Fowler's to enhance lung expansion

D) Monitor urine output to assess renal perfusion

A patient with worsening respiratory distress and hemodynamic instability is being considered for thrombolytic therapy. Which clinical sign should the nurse prioritize to report immediately that might contraindicate thrombolytic therapy?

C) Onset of new confusion and restlessness

A) Oxygen saturation dropping to 88%

B) Blood pressure decreasing to 82/54 mmHg

C) Onset of new confusion and restlessness

D) Elevated lactate level at 4.2 mmol/L

A patient with escalating respiratory distress and hemodynamic instability is being considered for thrombolytic therapy due to suspected right heart failure. Which clinical finding would most strongly support the immediate initiation of thrombolytic therapy?

B) Blood pressure of 82/54 mmHg with signs of confusion and restlessness

A) Oxygen saturation fluctuating between 85-90% despite high-flow oxygen

B) Blood pressure of 82/54 mmHg with signs of confusion and restlessness

C) Elevated lactate level of 4.2 mmol/L indicating anaerobic metabolism

A patient who has received thrombolytic therapy for a pulmonary embolism is showing mixed responses to the treatment. Which of the following nursing actions is most appropriate to prioritize at this time?

C) Conduct a neurological assessment to monitor for any changes in mental status.

A) Increase the high-flow oxygen setting to improve oxygen saturation.

B) Initiate a fluid bolus to further improve blood pressure and tissue perfusion.

C) Conduct a neurological assessment to monitor for any changes in mental status.

D) Prepare for ECMO initiation due to the rising BNP and persistent elevated lactate levels.

A patient is receiving thrombolytic therapy for a pulmonary embolism. After one hour, the patient's respiratory rate has decreased slightly, and oxygen saturation has stabilized at 90% on high-flow oxygen. However, her mental status remains concerning with ongoing confusion and anxiety. Her blood pressure is 90/60 mmHg, and lactate levels have decreased to 3.8 mmol/L. BNP levels continue to rise. Based on these findings, what is the most appropriate nursing action?

C) Continue to monitor the patient closely and prepare to escalate care if needed.

A) Increase the rate of IV fluids to enhance preload and improve blood pressure.

B) Prepare the patient for the initiation of ECMO due to persistent elevated BNP.

C) Continue to monitor the patient closely and prepare to escalate care if needed.

D) Administer a sedative to manage the patient's anxiety and confusion.

A patient receiving thrombolytic therapy for a pulmonary embolism develops hemoptysis and a decreased Glasgow Coma Scale (GCS) score. What is the most appropriate initial nursing intervention to address these complications?

C) Notify the healthcare provider immediately

A) Increase the rate of fluid resuscitation

B) Prepare for intubation and mechanical ventilation

C) Notify the healthcare provider immediately

D) Administer an additional dose of thrombolytic agent

A patient who received thrombolytic therapy for a pulmonary embolism begins to show signs of hemoptysis, a decreased Glasgow Coma Scale score, and worsening respiratory distress. What is the nurse's priority action?

D) Position the patient in a semi-Fowler's position to improve ventilation.

A) Administer a sedative to calm the patient.

B) Prepare the patient for immediate intubation.

C) Monitor vital signs every 15 minutes.

D) Position the patient in a semi-Fowler's position to improve ventilation.

Pulmonary Embolism - Nursing Case Study

Pathophysiology

• Primary mechanism: Pulmonary embolism occurs when a blood clot, usually originating from the deep veins of the legs (deep vein thrombosis), travels through the bloodstream and lodges in the pulmonary arteries, obstructing blood flow to the lung tissue.

• Secondary mechanism: The obstruction causes an increase in pulmonary vascular resistance, leading to elevated pressure in the right ventricle as it struggles to pump blood through the blocked arteries, potentially resulting in right ventricular dysfunction or failure.

• Key complication: The impaired blood flow reduces oxygenation capacity, causing hypoxemia and potential damage to lung tissue, which can lead to respiratory distress and, if untreated, may progress to life-threatening complications such as cardiogenic shock.

Patient Profile

Demographics:

45-year-old female, office manager

History:

• Key past medical history: Hypertension, history of deep vein thrombosis (DVT)

• Current medications: Lisinopril 10 mg daily, warfarin 5 mg daily

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Sudden onset of shortness of breath and chest pain

• Key symptoms: Dyspnea, pleuritic chest pain, mild hemoptysis, feeling of apprehension

• Vital signs: Blood pressure 98/65 mmHg, heart rate 110 bpm, respiratory rate 24 breaths per minute, oxygen saturation 88% on room air, temperature 37.2°C (99°F)

Section 1

As the medical team continues to assess the patient, further diagnostic imaging is conducted to confirm the presence and extent of the pulmonary embolism. A CT pulmonary angiogram reveals multiple emboli within the right and left pulmonary arteries, with a significant clot burden noted particularly in the right lower lobe. This finding correlates with the patient's clinical presentation of hypoxemia and pleuritic chest pain. Blood tests reveal an elevated D-dimer level, consistent with thrombotic activity, and an arterial blood gas analysis shows a pH of 7.33, PaCO2 of 48 mmHg, and PaO2 of 55 mmHg, indicating respiratory acidosis with significant hypoxemia.

In response to these findings, the clinical team initiates immediate anticoagulation therapy with intravenous heparin to prevent further clot formation. Oxygen supplementation is increased to maintain an oxygen saturation above 92%, and the patient is closely monitored for signs of hemodynamic instability. Despite these interventions, the patient's blood pressure continues to trend downward, now measuring 90/60 mmHg, raising concerns about the potential development of cardiogenic shock due to right ventricular strain.

Recognizing the risk of shock, the team considers additional interventions, such as thrombolytic therapy, to rapidly reduce the clot burden and alleviate pressure on the right heart. Meanwhile, frequent reassessment of the patient's clinical status is crucial to detect any progression towards right-sided heart failure or further respiratory compromise. The unfolding case highlights the necessity for vigilant monitoring and timely decision-making to prevent life-threatening complications in a patient with a significant pulmonary embolism.

Section 2

Change in Patient Status:

Shortly after initiating anticoagulation therapy and increasing oxygen support, the patient's condition starts to shift. Although the oxygen saturation is maintained above 92% with supplemental oxygen, the patient begins exhibiting signs of increased respiratory distress. Tachypnea is observed with a respiratory rate climbing to 32 breaths per minute, and the patient reports worsening dyspnea and anxiety. Auscultation of the lungs reveals diminished breath sounds in the right lower lobe, consistent with the location of the significant clot burden identified on the CT pulmonary angiogram. Additionally, the patient's jugular venous pressure is noted to be elevated, indicative of rising right heart pressures.

In response to these developments, the medical team intensifies monitoring, emphasizing the need to carefully balance fluid management, as aggressive fluid resuscitation could exacerbate right ventricular overload. The patient's blood pressure remains borderline at 88/58 mmHg despite cautious fluid administration, raising concerns about the adequacy of hemodynamic support. Laboratory tests show a further increase in troponin levels compared to the initial baseline, suggesting myocardial strain and potential right ventricular ischemia. Electrocardiogram findings reveal new right axis deviation and T-wave inversions in the anterior leads, further supporting the diagnosis of right ventricular strain.

The team continues to deliberate the use of thrombolytic therapy, weighing the benefits of reducing the clot burden against the risks of bleeding, particularly given the patient's hemodynamic instability and evidence of right heart strain. The decision to proceed with thrombolytics will depend on the patient's evolving clinical picture and the potential for rapid deterioration. As the patient remains under close observation, the team prepares for possible escalation of care, including the consideration of advanced interventions such as mechanical circulatory support if the patient's condition does not improve.

Section 3

New Complications:

As the team continues to monitor the patient closely, new complications emerge, signaling further deterioration. Despite the supplemental oxygen, the patient's respiratory distress intensifies, with tachypnea persisting and the respiratory rate now escalating to 36 breaths per minute. The patient's anxiety remains pronounced, and she now begins to exhibit confusion and restlessness, likely secondary to hypoxemia and potential cerebral hypoperfusion. Her oxygen saturation, previously stable, starts fluctuating, occasionally dropping to 88% even with high-flow oxygen. These changes prompt an immediate reassessment of her respiratory and hemodynamic status.

Further complicating the scenario, the patient's blood pressure drops to 82/54 mmHg, indicating worsening hemodynamic instability. The team re-evaluates the balance of fluid management, recognizing that any further reduction in preload could precipitate significant hemodynamic collapse. The decision to utilize thrombolytic therapy gains urgency in light of the escalating right ventricular strain. The latest laboratory results reveal a marked rise in B-type natriuretic peptide (BNP) levels, further corroborating right heart failure. Additionally, the lactate level is elevated at 4.2 mmol/L, suggesting a shift towards anaerobic metabolism due to inadequate tissue perfusion.

In this critical juncture, clinical reasoning becomes paramount as the team weighs the risks and benefits of thrombolytic therapy amidst the patient's precarious status. The emerging signs of altered mental status and hemodynamic instability underscore the potential for rapid deterioration, necessitating a swift yet calculated decision. As discussions progress, preparations are made for potential escalation to advanced interventions, including consideration for extracorporeal membrane oxygenation (ECMO) to provide both respiratory and circulatory support should the patient's condition continue to decline. The team remains vigilant, anticipating the next steps in this complex and evolving clinical scenario.

Section 4

As the team continues to navigate the complexities of the patient's condition, the focus shifts to her response to the initiated interventions, specifically the thrombolytic therapy. Within the first hour of administration, there is a cautious optimism as the patient's respiratory rate begins to decrease slightly, down to 30 breaths per minute. Her oxygen saturation stabilizes at around 90% on high-flow oxygen, providing a temporary reprieve from the earlier fluctuations. However, her mental status remains a concern; while there is a slight improvement in her restlessness, she still exhibits confusion and anxiety. This prompts the team to continuously monitor her neurological status, ensuring that any further decline is swiftly addressed.

Hemodynamically, her blood pressure shows marginal improvement, rising to 90/60 mmHg, yet it is still indicative of significant strain. The administration of fluids is carefully titrated to optimize preload without exacerbating the right ventricular failure. Repeat lab work reveals a modest decrease in lactate levels to 3.8 mmol/L, suggesting a potential improvement in tissue perfusion, though it remains elevated. The BNP level, however, continues to rise, reaching 1100 pg/mL, reinforcing the ongoing right heart strain.

Despite these mixed responses, the team remains vigilant. The slight improvements are encouraging, but the persistent elevation in BNP and the elevated lactate levels highlight the need for continuous assessment and readiness to escalate care if necessary. Discussions around ECMO are revisited, with the team preparing for a potential transition should the patient fail to maintain this tenuous stability. The multidisciplinary team, including cardiology and critical care specialists, collaborates closely, ensuring that all potential interventions are considered and ready to be implemented swiftly to prevent further deterioration.

Section 5

As the team continues to monitor the patient closely, her status begins to change, highlighting new complications that demand immediate attention. Approximately two hours post-thrombolytic therapy, the patient develops hemoptysis, coughing up small amounts of blood. This alarming development raises concerns about potential bleeding risks associated with the thrombolytic treatment. While the bleeding appears limited, the team is acutely aware of the need to balance the risk of bleeding with the ongoing management of the pulmonary embolism. Her blood pressure remains marginal at 88/58 mmHg, and fluid resuscitation is cautiously continued under careful monitoring of her hemodynamic status.

Compounding the concern, the patient's mental status shows further deterioration; she becomes increasingly lethargic, with a Glasgow Coma Scale (GCS) score dropping to 12. This change prompts an urgent reevaluation of her neurological function. A stat head CT is ordered to rule out intracranial bleeding, a known complication of thrombolytic therapy. Meanwhile, her respiratory status becomes more labored, with a slight increase in respiratory rate to 32 breaths per minute and a decrease in oxygen saturation to 88% despite high-flow oxygen. The team considers escalating respiratory support, discussing the possibility of non-invasive ventilation to alleviate her respiratory distress and improve oxygenation.

The multidisciplinary team huddles to re-evaluate the treatment plan in light of these new developments. Discussions around ECMO intensify as a proactive measure, considering the patient's tenuous respiratory and hemodynamic stability. The rising BNP and persistent lactate elevation remain points of concern, underscoring the significant strain on her cardiovascular system. The team also deliberates on the potential need to adjust the anticoagulation regimen, balancing the benefits of thrombolysis against the bleeding risk. This evolving situation necessitates a strategic, coordinated approach to adjust interventions swiftly while anticipating further complications, setting the stage for the next critical decisions in the patient's care trajectory.